Ning Zhang
Vice Director
Pharmacology
Dalian Medical University
China
Biography
BSc in Clinical Pharmacy, Dalian Medical University, Dalian, P. R. China, 1993 to 1998,MSc in Pharmacology, Dalian Medical University, Dalian, P. R. China, 2000 to 2003
Research Interest
Chinese & Western Combining Pharmacology,
Publications
-
Zeng W, Shan W, Gao L, Gao D, Hu Y, Wang G,Zhang N, Li Z, Tian X, Xu W, Peng J, Ma X, Yao J. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Sci Rep.，2015，3；5:16013
-
Xin XL, Dong PP, Sun XH, Deng S,Zhang N, Wang C, Huo XK, Li Y, Lan R, Chen L, Fan GJ. Identification of the hydroxylated derivatives of bufalin: phase I metabolites in rats. J Asian Nat Prod Res.，2015，17(4):1-9
-
Wanqiu Li, Xia Lin, Zhenhua Yang, Wei Zhang, Tianyang Ren, Fengming Qu, Yanjiao Wang, Ning Zhang*, Xing Tang*，A bufadienolide-loaded submicron emulsion for oral administration: Stability, antitumor efficacy and toxicity.，Int J Pharm, 2015，79(1):52-62
